Armin Gerbitz

4.0k total citations
107 papers, 2.6k citations indexed

About

Armin Gerbitz is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Armin Gerbitz has authored 107 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 38 papers in Immunology and 22 papers in Oncology. Recurrent topics in Armin Gerbitz's work include Hematopoietic Stem Cell Transplantation (60 papers), Immune Cell Function and Interaction (22 papers) and Acute Lymphoblastic Leukemia research (19 papers). Armin Gerbitz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (60 papers), Immune Cell Function and Interaction (22 papers) and Acute Lymphoblastic Leukemia research (19 papers). Armin Gerbitz collaborates with scholars based in Canada, Germany and United States. Armin Gerbitz's co-authors include James L.M. Ferrara, Ernst Holler, Geoffrey R. Hill, Kenneth R. Cooke, Takanori Teshima, James M. Crawford, Reinhard Andreesen, Andrea Wilke, Yani S. Brinson and Luying Pan and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Armin Gerbitz

99 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armin Gerbitz Canada	23	1.4k	1.1k	646	468	293	107	2.6k
Makoto Onizuka Japan	24	1.5k 1.1×	853 0.8×	445 0.7×	425 0.9×	253 0.9×	201	2.4k
Kazuhiro Ikegame Japan	27	1.4k 1.0×	715 0.7×	876 1.4×	494 1.1×	234 0.8×	154	2.7k
John J. Cush United States	31	1.2k 0.8×	1.6k 1.5×	461 0.7×	529 1.1×	399 1.4×	59	4.3k
Nobuharu Fujii Japan	25	781 0.6×	786 0.7×	675 1.0×	358 0.8×	167 0.6×	154	2.0k
Yasushi Takamatsu Japan	27	1.6k 1.1×	1.1k 1.0×	1.3k 2.1×	695 1.5×	549 1.9×	159	3.6k
John M. McCarty United States	23	1.8k 1.3×	856 0.8×	983 1.5×	590 1.3×	365 1.2×	70	3.6k
Zafer Gülbaş Türkiye	24	1.2k 0.9×	426 0.4×	580 0.9×	277 0.6×	240 0.8×	142	2.1k
Jack Bleesing United States	35	1.8k 1.3×	2.7k 2.5×	543 0.8×	545 1.2×	379 1.3×	108	4.0k
Xingmin Feng United States	29	1.8k 1.3×	1.1k 1.1×	412 0.6×	503 1.1×	535 1.8×	102	2.9k
Kíyoyuki Ogata Japan	23	1.5k 1.1×	841 0.8×	582 0.9×	388 0.8×	510 1.7×	84	2.3k

Countries citing papers authored by Armin Gerbitz

Since Specialization

Citations

This map shows the geographic impact of Armin Gerbitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Gerbitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Gerbitz more than expected).

Fields of papers citing papers by Armin Gerbitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armin Gerbitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Gerbitz. The network helps show where Armin Gerbitz may publish in the future.

Co-authorship network of co-authors of Armin Gerbitz

This figure shows the co-authorship network connecting the top 25 collaborators of Armin Gerbitz. A scholar is included among the top collaborators of Armin Gerbitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armin Gerbitz. Armin Gerbitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Remberger, Mats, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation. Cancers. 17(4). 651–651.

Pašić, Ivan, Mats Remberger, Carol Chen, et al.. (2024). Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study. Transplantation and Cellular Therapy. 30(7). 681.e1–681.e11. 2 indexed citations

Pašić, Ivan, Arjun Law, Wilson Lam, et al.. (2024). Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience. European Journal Of Haematology. 113(4). 477–484. 3 indexed citations

Remberger, Mats, Carol Chen, Igor Novitzky‐Basso, et al.. (2024). PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation. Blood Advances. 9(3). 660–669. 7 indexed citations

Salas, María Queralt, Eshetu G. Atenafu, Arjun Law, et al.. (2024). Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 30(5). 536.e1–536.e13. 4 indexed citations

Novitzky‐Basso, Igor, Christopher J. Patriquin, Ivan Pašić, et al.. (2023). Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD. Transplantation and Cellular Therapy. 29(12). 773.e1–773.e10. 3 indexed citations

Novitzky‐Basso, Igor, Ivan Pašić, Wilson Lam, et al.. (2023). A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment Outcomes. Hematology/Oncology and Stem Cell Therapy. 17(1). 60–71. 2 indexed citations

Lee, Katherine J., Shiyi Chen, Arjun Law, et al.. (2021). Weight Loss after Allogeneic Stem Cell Transplantation Is Associated with Increased Mortality. Transplantation and Cellular Therapy. 27(3). S181–S182. 1 indexed citations

Lipton, Jeffrey H., Dennis Dong Hwan Kim, Auro Viswabandya, et al.. (2021). Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients. Clinical Lymphoma Myeloma & Leukemia. 22(5). e327–e334. 4 indexed citations

10.

Law, Arjun, Sita Bhella, Ivan Pašić, et al.. (2021). Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation. Annals of Hematology. 100(5). 1311–1319.

11.

Salas, María Queralt, Eshetu G. Atenafu, Wilson Lam, et al.. (2020). High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications. PubMed. 3(3). 48–58. 1 indexed citations

12.

Nampoothiri, Ram Vasudevan, Shiyi Chen, Ivan Pašić, et al.. (2020). Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation. Hematology/Oncology and Stem Cell Therapy. 14(2). 134–140.

13.

Salas, María Queralt, Eshetu G. Atenafu, Wilson Lam, et al.. (2020). Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 56(1). 60–69. 18 indexed citations

14.

Schultze‐Florey, Christian, Christophe Peczynski, Emmanuelle Polge, et al.. (2019). Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis. Bone Marrow Transplantation. 55(8). 1642–1646. 1 indexed citations

15.

Gary, Regina, Michael Aigner, Stefanie Schaffer, et al.. (2018). Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. Journal of Translational Medicine. 16(1). 124–124. 13 indexed citations

16.

Brunner, Stefan, Bruno Hüber, Tobias Weinberger, et al.. (2011). Migration of bone marrow‐derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarction. Journal of Cellular and Molecular Medicine. 16(1). 152–159. 9 indexed citations

17.

Gerbitz, Armin, Christoph Schmid, Andrea Wilke, et al.. (2008). Influence of Polymorphism within the Heme Oxygenase-I Promoter on Overall Survival and Transplantation-Related Mortality after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 14(10). 1180–1189. 13 indexed citations

18.

Reddy, Vijay, Geoffrey R. Hill, Luying Pan, et al.. (2000). G-CSF MODULATES CYTOKINE PROFILE OF DENDRITIC CELLS AND DECREASES ACUTE GRAFT-VERSUS-HOST DISEASE THROUGH EFFECTS ON THE DONOR RATHER THAN THE RECIPIENT. Transplantation. 69(4). 691–693. 73 indexed citations

19.

Gerbitz, Armin, Josef Mautner, Christian Geltinger, et al.. (1999). Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma. Oncogene. 18(9). 1745–1753. 46 indexed citations

20.

Hill, Geoffrey R., Takanori Teshima, Armin Gerbitz, et al.. (1999). Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia. Journal of Clinical Investigation. 104(4). 459–467. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact